Results 151 to 160 of about 418,673 (161)

Similar efficacy and safety of LY2963016 insulin glargine and insulin glargine (Lantus®) in patients with type 2 diabetes who were insulin-naïve or previously treated with insulin glargine: a randomized, double-blind controlled trial (the ELEMENT 2 study)

Diabetes, Obesity and Metabolism, 2015
J Rosenstock, M J Prince, L L Ilag
exaly  

Lower Within-Subject Variability of Insulin Detemir in Comparison to NPH Insulin and Insulin Glargine in People With Type 1 Diabetes

Diabetes, 2004
Tim Heise, Christoph Kapitza, Lutz Heinemann   +2 more
exaly  

Clinical relevance of pharmacokinetic and pharmacodynamic profiles of insulin degludec (100, 200 U/mL) and insulin glargine (100, 300 U/mL) – a review of evidence and clinical interpretation

Diabetes and Metabolism, 2019
David R Owens, Carmine Giuseppe Fanelli, Geremia B Bolli   +2 more
exaly  

Treatment satisfaction and psychological well-being with insulin glargine compared with NPH in patients with Type 1 diabetes

Diabetic Medicine, 2001
Clare Bradley
exaly  

Efficacy and safety of LY2963016 insulin glargine compared with insulin glargine (Lantus®) in patients with type 1 diabetes in a randomized controlled trial: the ELEMENT 1 study

Diabetes, Obesity and Metabolism, 2015
J Rosenstock, M J Prince, L L Ilag
exaly  

Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group

Diabetologia, 2009
Helen M. Colhoun
exaly  

Glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus insulin glargine 100 U/ml in people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: the EDITION 2 randomized 12-month trial including 6-month extension

Diabetes, Obesity and Metabolism, 2015
M Wardecki
exaly  

Negative Binomial Meta-Regression Analysis of Combined Glycosylated Hemoglobin and Hypoglycemia Outcomes Across Eleven Phase III and IV Studies of Insulin Glargine Compared with Neutral Protamine Hagedorn Insulin in Type 1 and Type 2 Diabetes Mellitus

Clinical Therapeutics, 2007
Hannele Yki-Järvinen, Matthew C Riddle, Hans-Ulrich Häring   +2 more
exaly  

Cancer Incidence Among Those Initiating Insulin Therapy With Glargine Versus Human NPH Insulin

Diabetes Care, 2013
Lisa Morrissey LaVange, Soo Lim
exaly  

New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Basal and Mealtime Insulin: Glucose Control and Hypoglycemia in a 6-Month Randomized Controlled Trial (EDITION 1)

Diabetes Care, 2014
Philip D Home, Matthew C Riddle, Geremia B Bolli   +2 more
exaly